A detailed history of Financial Sense Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Sense Advisors, Inc. holds 17,699 shares of ABBV stock, worth $3.11 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
17,699
Previous 17,968 1.5%
Holding current value
$3.11 Million
Previous $3.08 Million 13.44%
% of portfolio
1.08%
Previous 1.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $44,072 - $53,619
-269 Reduced 1.5%
17,699 $3.5 Million
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $842,521 - $983,876
5,443 Added 43.46%
17,968 $3.08 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $138,244 - $157,516
-865 Reduced 6.46%
12,525 $2.28 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $105,126 - $118,397
764 Added 6.05%
13,390 $2.08 Million
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $516,859 - $598,340
-3,869 Reduced 23.46%
12,626 $1.88 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $173,720 - $216,183
1,311 Added 8.63%
16,495 $2.22 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $29,789 - $34,307
206 Added 1.38%
15,184 $2.42 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $346,051 - $415,006
2,502 Added 20.05%
14,978 $2.42 Million
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $5,368 - $6,157
-40 Reduced 0.32%
12,476 $1.67 Million
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $1.52 Million - $1.94 Million
11,077 Added 769.77%
12,516 $1.92 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $1.49 Million - $1.85 Million
-11,317 Reduced 88.72%
1,439 $233,000
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $4,619 - $5,844
-43 Reduced 0.34%
12,756 $1.73 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $281,960 - $320,067
2,650 Added 26.11%
12,799 $1.38 Million
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $49,343 - $54,971
-469 Reduced 4.42%
10,149 $1.14 Million
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $9,616 - $10,586
94 Added 0.89%
10,618 $1.15 Million
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $48,213 - $65,093
-599 Reduced 5.39%
10,524 $1.13 Million
Q3 2020

Oct 21, 2020

SELL
$85.91 - $100.83 $62,112 - $72,900
-723 Reduced 6.1%
11,123 $974,000
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $171,025 - $228,857
-2,331 Reduced 16.44%
11,846 $1.16 Million
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $914,416 - $1.39 Million
14,177 New
14,177 $1.08 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $248,771 - $299,094
-3,950 Closed
0 $0
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $92,965 - $118,831
1,415 Added 55.82%
3,950 $287,000
Q1 2019

May 06, 2019

BUY
$77.14 - $90.79 $195,549 - $230,152
2,535 New
2,535 $204,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Sense Advisors, Inc. Portfolio

Follow Financial Sense Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Sense Advisors, Inc. with notifications on news.